World Asset Management Inc - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
World Asset Management Inc ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$243,000
+10.0%
10,451
-24.6%
0.01%
+20.0%
Q1 2018$221,000
-46.0%
13,863
-29.5%
0.01%
-28.6%
Q4 2017$409,000
+39.6%
19,663
-3.8%
0.01%
+40.0%
Q3 2017$293,000
-17.2%
20,432
-0.3%
0.01%
-16.7%
Q2 2017$354,000
+49.4%
20,486
-4.7%
0.01%
+50.0%
Q1 2017$237,000
-22.8%
21,502
+1.5%
0.01%
-33.3%
Q4 2016$307,000
-45.8%
21,174
-8.1%
0.01%
-40.0%
Q3 2016$566,000
+32.9%
23,045
+9.0%
0.02%
+25.0%
Q2 2016$426,000
-17.0%
21,135
+8.4%
0.02%
-20.0%
Q1 2016$513,000
-72.1%
19,496
+7.8%
0.02%
-71.4%
Q4 2015$1,839,000
-41.7%
18,091
+2.4%
0.07%
-46.2%
Q3 2015$3,153,000
-12.2%
17,674
+9.3%
0.13%
-7.8%
Q2 2015$3,591,000
+5.8%
16,163
-5.4%
0.14%
+20.5%
Q1 2015$3,394,000
+38.6%
17,089
-0.1%
0.12%
+39.3%
Q4 2014$2,448,000
+8.3%
17,109
-0.7%
0.08%
+23.5%
Q3 2014$2,261,000
-1.4%
17,234
-5.2%
0.07%
-2.9%
Q2 2014$2,293,000
-7.1%
18,180
-2.9%
0.07%
-9.1%
Q1 2014$2,469,000
+0.7%
18,729
-10.3%
0.08%
+13.2%
Q4 2013$2,452,000
-15.0%
20,883
-24.5%
0.07%
-5.6%
Q3 2013$2,885,000
+10.4%
27,654
-8.9%
0.07%
+18.0%
Q2 2013$2,614,00030,3640.06%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2018
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders